HPR49 Real World Evidence and Rare Disease Considerations Across Regulatory and Health Technology Assessment Frameworks in the US, UK, and Canada
Abstract
Authors
L Blackmore KA Cribbs BJ Lahue
L Blackmore KA Cribbs BJ Lahue
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now